GeneDx Holdings Faces Investor Lawsuit Over Alleged Securities Fraud

A class action lawsuit has been initiated against GeneDx Holdings Corp., accusing the company of securities fraud. This legal action comes after a substantial decline in the company's share price, which followed the release of disappointing first-quarter financial results. These results included a reduced gross margin, lowered earnings forecasts, and an impairment charge related to a previous acquisition.